XBIT
HealthcareXBiotech Inc.
$2.44
+$0.06 (+2.52%)
Jan 5, 2026
Price History (1Y)
Analysis
XBiotech Inc. is a biotechnology company in the healthcare sector with a market capitalization of $74.39M. It has 88 employees. The company's financial health is characterized by significant losses, with net income and EBITDA both totaling -$29.2 million and -$32.9 million, respectively. Free cash flow was -$18.5 million. Gross margin, operating margin, and profit margin were all at 0%. Return on equity (ROE) was -16.2%, while return on assets (ROA) was -11.3%. XBiotech Inc.'s valuation metrics include a forward P/E ratio of 18.77 and an EV/EBITDA of 2.22. The company's price to book ratio is 0.45, and its cash balance is $147.37 million.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Visit website →Key Statistics
- Market Cap
- $74.39M
- P/E Ratio
- N/A
- 52-Week High
- $4.54
- 52-Week Low
- $2.09
- Avg Volume
- 103.23K
- Beta
- 0.80
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 88